Related Experiment Video
Updated: Jun 22, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Panel-reactive screening and treatment practices following bridge to transplantation ventricular assist device
R S Freudenberger1, I Tawfik, M Shinnar
1Center for Advanced Heart Failure, Lehigh Valley Health Network, Allentown, Pennsylvania 18103, USA.
Abstract:
The use of left ventricular assist devices (LVAD) as a bridge to transplantation is associated with the development of circulating antibodies. We conducted a survey of all adult cardiac transplantation programs in the United States in an attempt to define current practices with regard to LVAD implantation, monitoring panel-reactive antibody (PRA) levels, treatment options, and peritransplantation management. Pretransplantation sensitization with the use of LVAD is a concern to the majority of transplantation professionals and there is no consensus on the need or mode of treatment.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Cardiac Catheterization I: Pre-Procedure Overview
